What is Vamstar?
Founded in 2019, Vamstar operates at the intersection of artificial intelligence and healthcare logistics. The company provides a sophisticated B2B marketplace that streamlines the procurement of pharmaceutical products, medical devices, and specialized healthcare services. By replacing manual, fragmented processes with an automated, data-rich environment, Vamstar enables healthcare providers and suppliers to optimize their contract negotiations and supply chain efficiency. Its platform serves as a centralized hub, reducing administrative overhead while increasing transparency in a traditionally opaque industry.
How much funding has Vamstar raised?
Vamstar has raised a total of $11.2M across 2 funding rounds:
Angel/Seed
$1.7M
Series A
$9.5M
Angel/Seed (2021): $1.7M with participation from Antler Ltd, Begin Capital, and Btov
Series A (2022): $9.5M led by Dutch Founders Fund and Alpha Intelligence Capital
Key Investors in Vamstar
Dutch Founders Fund
An Amsterdam-based venture capital firm founded by successful entrepreneurs, specializing in marketplaces and companies with strong network effects.
Antler Ltd
A global early-stage venture capital firm that builds and invests in the world's most promising startups from the earliest stages.
Btov
A European venture capital firm focusing on digital and industrial technology companies, providing both capital and deep industry expertise.
What's next for Vamstar?
With the successful closure of its latest funding round, Vamstar is poised to transition from a high-growth startup to an established enterprise-level player. The strategic focus will likely shift toward deepening its AI capabilities to provide predictive analytics for supply chain resilience and expanding its footprint in key global markets. As healthcare systems continue to prioritize digital transformation, Vamstar's ability to integrate seamlessly into existing procurement ecosystems will be a primary driver of its long-term value proposition. The company is well-positioned to capitalize on the increasing demand for automated, scalable B2B solutions in the medical sector.
See full Vamstar company page
